Venetoclax use in a patient with ataxia telangiectasia and early T‐cell precursor acute lymphoblastic leukemia
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.31123 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Shaikha Alqahtani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Bridged Bicyclo Compounds, Heterocyclic, Ataxia Telangiectasia, Sulfonamides, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Hematopathology, Division of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
ORCID-Profile: Shaikha Alqahtani, David McCall, Miriam B Garcia, Michael E Roth, Amber Gibson
Zitieren
APA
Alqahtani, S., Ramakrishnan, R., E, S., Wang, S. A., Nunez, C., McCall, D., Garcia, M. B., Roth, M. E., Cuglievan, B., & Gibson, A. (2024). Venetoclax use in a patient with ataxia telangiectasia and early T‐cell precursor acute lymphoblastic leukemia. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31123
Vancouver
Alqahtani S, Ramakrishnan R, E S, Wang SA, Nunez C, McCall D, et al. Venetoclax use in a patient with ataxia telangiectasia and early T‐cell precursor acute lymphoblastic leukemia. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31123
BibTeX
@article{Alqahtani2024,
author = {Alqahtani, Shaikha and Ramakrishnan, Ramya and E, Shuyu and Wang, Sa A and Nunez, Cesar and McCall, David and Garcia, Miriam B and Roth, Michael E and Cuglievan, Branko and Gibson, Amber},
title = {Venetoclax use in a patient with ataxia telangiectasia and early T‐cell precursor acute lymphoblastic leukemia},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.31123}
}
EUVIMED